Hengsheng Group: A Mixed Bag in the First Half of 2025 Hengsheng Group’s 2025 half-year results reveal a story of contrasting fortunes. While the toy business showed robust growth, the mask segment significantly underperformed. This report holds critical clues to Hengsheng’s future. We’ll delve into key business performance, new ventures, and potential risks to provide … Read more
Asset Management Firm Bets on SMCG! Are You Ready to Seize the Opportunity? The stock price of SMCG (460870), a cosmetic glass container ODM company, is showing unusual movement. Investor interest is intensifying with the news of a specific asset management firm acquiring a 5% stake. Having successfully turned to profit after listing on KOSDAQ … Read more
CSA Cosmic: Major Shareholder Divests Stake – Opportunity or Risk? CSA Cosmic’s largest shareholder, Seong-A Cho, has sold a 4.86% stake, drawing significant attention from investors. How will this divestiture impact CSA Cosmic’s future, given the contrasting performance of its struggling cosmetics business and its growing construction materials sector? This article analyzes the background of … Read more
Can iCure Escape Delisting? iCure (175250)’s delisting review has been extended, increasing investor anxiety. Despite improved financials and growth in the cosmetics business, the possibility of delisting remains. This article analyzes iCure’s current situation, provides future outlook, and guides investors on the actions they should take. What Happened? On August 27, 2025, iCure announced that … Read more
Neopharm, a Leading Sensitive Skincare Brand, Takes a Leap Forward Globally! Neopharm, the company behind ‘Atopalm,’ which has held the No. 1 spot in the K-BPI ‘Sensitive Skincare Category’ for 19 consecutive years, recently held an IR for overseas investors. This IR is expected to be a significant opportunity to showcase Neopharm’s growth potential to … Read more
APR Announces Q2 Earnings: Is it an Investment Opportunity? APR, a beauty and healthcare company, will hold an Investor Relations (IR) session on September 1st. Having recorded strong performance in Q2, what growth strategies will APR present at this IR? This article analyzes APR’s Q2 earnings, future stock outlook, and key points for investors to … Read more
Global Tax Free: Taking Off with Tax Refunds? Global Tax Free is enjoying a boom in its tax refund business thanks to the increasing number of inbound tourists. However, the company is facing challenges with its struggling cosmetics and webtoon businesses. Can the August 28th IR meeting paint a positive picture for the future? This … Read more
Kolmar Korea’s Q2 Earnings: An Investment Opportunity? Kolmar Korea held its Investor Relations (IR) meeting on August 27, 2025. This meeting, covering Q2 2025 earnings and management performance, offers valuable insights into the company’s future direction, capturing significant investor attention. This article provides a comprehensive analysis of the key IR takeaways and suggests potential investment … Read more
Hyundai Bioland: Poised for a Leap Forward Amidst Change Hyundai Bioland, recently impacted by the sale of a subsidiary and subsequent decline in performance, held an investor relations (IR) meeting on August 28, 2025. This IR meeting was more than a simple report on current management status; it served as a crucial platform to showcase … Read more
CSA Cosmic: New Ownership on the Horizon? Investors Take Note! News of a potential change in CSA Cosmic’s major shareholder has caught the attention of investors. The company, operating in cosmetics and construction materials, has faced challenges with recent performance declines and frequent changes in ownership. Could this change be a positive turning point, or … Read more